Nano Holdings, Inc. (TYO:4571)
69.00
-1.00 (-1.43%)
Nov 18, 2026, 10:19 AM JST
Nano Holdings Revenue
Nano Holdings had revenue of 42.00M JPY in the quarter ending September 30, 2026, with 23.53% growth. This brings the company's total for the last twelve months to 210.00M, up 47.89% year-over-year. In the fiscal year ending March 31, 2026, Nano Holdings had annual revenue of 174.00M with 61.11% growth. That makes Nano Holdings the 43,190th largest company in the world by revenue and 3,859th in Japan.
Revenue (ttm)
210.00M
Revenue Growth
+47.89%
P/S Ratio
30.35
Revenue / Employee
9.13M
Employees
23
Market Cap
6.28B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 174.00M | 66.00M | 61.11% |
| Mar 31, 2025 | 108.00M | -27.00M | -20.00% |
| Mar 31, 2024 | 135.00M | -67.00M | -33.17% |
| Mar 31, 2023 | 202.00M | 84.18M | 71.45% |
| Mar 31, 2010 | 117.82M | -235.83M | -66.68% |
| Mar 31, 2009 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2008 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2007 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2006 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Soiken Holdings | 3.87B |
| CellSource | 3.67B |
| StemCell Institute | 2.81B |
| OncoTherapy Science | 712.00M |
| Chiome Bioscience | 615.15M |
| Cyfuse Biomedical K.K. | 305.00M |
| CellSeed | 161.00M |
| ADR Biomedical Holdings | 101.00M |